Back to libraryStress & Recovery

Neuropeptide Y (NPY)

Research profile · How we handle evidence

Neuropeptide Y is an endogenous 36-amino-acid neuropeptide, first sequenced from porcine brain in 1982, and one of the most abundant peptides in the mammalian central and peripheral nervous system. It is a central driver of feeding behavior and is heavily studied in stress-resilience and anxiety research.

Evidence Score

45/100

Preclinical signal

Category

Stress & Recovery

Therapeutic area

Standard Dose

Research dosing only (not established for humans)

Research context only

Half-life

-

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

NPY is a natural brain-and-body signaling peptide, not a marketed drug. It's best known in research for two roles that seem opposite but aren't: it's one of the strongest known appetite-stimulating signals, and it's also a major focus of stress-resilience research (including PTSD studies) because higher NPY signaling is associated with better coping under acute stress. It's sold as a research reagent, not something with an established self-administration protocol.

Mechanism of Action

NPY is a natural brain-and-body signaling peptide, not a marketed drug. It's best known in research for two roles that seem opposite but aren't: it's one of the strongest known appetite-stimulating signals, and it's also a major focus of stress-resilience research (including PTSD studies) because higher NPY signaling is associated with better coping under acute stress. It's sold as a research reagent, not something with an established self-administration protocol.

Y Receptor Family Agonism (Y1/Y2/Y5)Hypothalamic Feeding Behavior SignalingAmygdala Linked Stress/Anxiety Modulation

Benefits

  • Central appetite/feeding-behavior stimulant in animal models
  • Studied for a role in stress resilience and anxiety modulation
  • Studied in cardiovascular and circadian-rhythm research contexts

Side Effects

  • No established human dosing safety profile outside of research settings
  • Potent appetite stimulation is itself a notable effect, not a side effect to be dismissed
  • Effects are highly context- and route-dependent (central vs. peripheral administration) in the animal literature

Contraindications

  • No established human therapeutic use - research reagent only
  • Not evaluated for pregnancy, pediatric, or long-term safety

Structure & Sequence

Verified structure

Neuropeptide Y (NPY)

Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.

Sequence-backed
4,271.76 DaCAS 90880-35-636 residues
Amino Acid Sequence
YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2
Molecular Weight
4,271.76 Da
CAS Number
90880-35-6

Stack & Route Context

Stacks with

No entries listed.

Administration

Subcutaneous

Research Status

Extensively studied endogenous neuropeptide with decades of preclinical (rodent, primate) literature. No human clinical development as a standalone therapeutic; research use is almost entirely in vitro or in animal models.

Approval Status

Preclinical

Sports Legal

Permitted

References

  1. 1

    Neuropeptide Y: complete amino acid sequence of the brain peptide

    1982

    View source
  2. 2

    Neuropeptide Y: complete amino acid sequence of the brain peptide (PMC)

    1982

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.